Patients receiving care for advanced cancer were more likely to survive or experience a longer period without their disease progressing if they received personalized cancer therapy, report researchers.
Patients receiving care for advanced cancer were more likely to survive or experience a longer period without their disease progressing if they received personalized cancer therapy, report researchers.